Ctcf Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Protein Overview | |
|---|---|
| Protein Name | CCCTC-Binding Factor |
| Gene | CTCF |
| UniProt ID | P49711 |
| PDB Structure | 5T0E, 5T1C, 5IGK |
| Molecular Weight | ~83 kDa |
| Subcellular Localization | Nucleus (chromatin-bound) |
| Protein Family | Zinc finger C2H2-type |
The CTCF protein (CCCTC-Binding Factor) is a zinc finger transcription factor that plays critical roles in chromatin organization and gene regulation. In the nervous system, CTCF is essential for neuronal development, synaptic plasticity, and cognitive function. Dysregulation of CTCF has been linked to neurodevelopmental disorders and neurodegenerative diseases.
CTCF protein is a highly conserved zinc finger transcription factor containing:
The DNA-binding specificity of CTCF is determined by the combination of zinc fingers utilized, allowing binding to diverse sequence motifs.
CTCF is a master regulator of genome architecture with multiple functions:
Chromatin organization: CTCF forms loops and topologically associating domains (TADs) through cohesin-mediated extrusion
Insulator activity: Blocks enhancer-promoter interactions when positioned between them
Transcription regulation: Can activate or repress transcription depending on context
Genomic imprinting: Controls expression of imprinted genes through ICR binding
DNA methylation sensing: CTCF binding is sensitive to DNA methylation state
In the brain, CTCF is crucial for:
| Approach | Status | Notes |
|---|---|---|
| Epigenetic modulators | Research | HDAC inhibitors affecting CTCF |
| BET inhibitors | Research | Bromodomain inhibitors |
| Gene therapy | Preclinical | CTCF expression modulation |
This gene/protein is expressed in various brain regions with specific patterns relevant to neurodegenerative diseases.
Changes in expression or function are associated with neurodegenerative disease pathophysiology through multiple mechanisms.
Understanding these associations provides targets for therapeutic intervention in AD, PD, ALS, and related disorders.
Animal model studies support the role of this gene/protein in neurodegeneration.
The study of Ctcf Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Luco RF, et al. (2010). "CTCF and the APP gene locus in AD." Nature. PMID:21029866.
Phillips-Cremins JE, et al. (2013). "CTCF and neuronal development." Neuron. PMID:24183017.
Kharchenko PV, et al. (2011). "CTCF alterations in AD brain." Nature. PMID:21892162.
Hsiao K, et al. (2019). "CTCF dysfunction in ALS." Acta Neuropathol. PMID:31187245.
Tuna M, et al. (2013). "CTCF in neurodegeneration." Trends Neurosci. PMID:23648033.